P1066: PEMBROLIZUMAB MONOTHERAPY AS A FIRST THERAPY FOR HODGKIN LYMPHOMA IS DELIVERABLE IN OLDER OR ABVD INELIGIBLE PATIENTS, DOES NOT PRECLUDE SUBSEQUENT THERAPY, AND PROVIDES ADEQUATE SURVIVAL.
Authors: Michael Dickinson, Leanne Berkahn, Judith Trotman, Jason Butler, Paul Neeson, Matthias Bressel, Adrian Minson